CMMB
Chemomab Therapeutics
$1.42
+$0.06 (+4.41%)Jul 27, 2026
Key metrics
The numbers that frame CMMB today
- Market cap
- $10.62M
- P/E (TTM)
- -1.2
- EV / FCF
- -0.3
- ROIC
- -234.1%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.35
- 52wk High
- $4.80
Growth
Revenue and earnings trend for CMMB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CMMB
Is Chemomab Therapeutics a good buy?
No. Chemomab Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks strong, which supports the long-term business case, but that is not enough to offset the weak setup. We think Chemomab Therapeutics is selling at a very high price.
What is the market capitalization of CMMB?
Chemomab Therapeutics's market capitalization is $10.62M.
What is the P/E ratio for CMMB stock?
Chemomab Therapeutics's current P/E ratio is -1.2.
What is the 52-week high for CMMB stock?
The 52-week high for Chemomab Therapeutics is $4.80. The current close of $1.42 is 70.4% below that high.
What is the 52-week low for CMMB stock?
The 52-week low for Chemomab Therapeutics is $1.35. The current close of $1.42 is 5.2% above that low.
Does CMMB stock pay dividends?
Chemomab Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CMMB?
Chemomab Therapeutics's Debt / Equity ratio is 0.